相似文献
1
Formulary Drug Review: Sufentanil Sublingual.
Hosp Pharm. 2019 Aug;54(4):222-228. doi: 10.1177/0018578719851726. Epub 2019 May 29.
2
Formulary Drug Review: Edaravone.
Hosp Pharm. 2017 Dec;52(11):732-736. doi: 10.1177/0018578717734877. Epub 2017 Oct 9.
3
Formulary Drug Review: Ocrelizumab.
Hosp Pharm. 2017 Oct;52(9):599-606. doi: 10.1177/0018578717731733. Epub 2017 Sep 17.
4
Formulary Drug Review: Betrixaban.
Hosp Pharm. 2018 Feb;53(1):29-37. doi: 10.1177/0018578717739397. Epub 2017 Nov 6.
5
Angiotensin II.
Hosp Pharm. 2018 Jul;53(4):230-233. doi: 10.1177/0018578718778224. Epub 2018 May 24.
6
Omadacycline.
Hosp Pharm. 2019 Apr;54(2):80-87. doi: 10.1177/0018578718823730. Epub 2019 Jan 22.
7
Sodium Zirconium Cyclosilicate.
Hosp Pharm. 2019 Feb;54(1):12-19. doi: 10.1177/0018578718817470. Epub 2018 Dec 14.
8
Baloxavir Marboxil.
Hosp Pharm. 2019 Jun;54(3):165-169. doi: 10.1177/0018578719841044. Epub 2019 Apr 1.
9
Zoster Vaccine Recombinant, Adjuvanted.
Hosp Pharm. 2018 Jun;53(3):136-141. doi: 10.1177/0018578718767103. Epub 2018 Apr 2.
10
Sugammadex.
Hosp Pharm. 2016 Jul;51(7):585-96. doi: 10.1310/hpj5107-585.
引用本文的文献
1
Low-dose sufentanil does not affect tolerance to LBNP-induced central hypovolemia or blood pressure responses during a cold pressor test.
Am J Physiol Regul Integr Comp Physiol. 2024 Nov 1;327(5):R497-R507. doi: 10.1152/ajpregu.00003.2024. Epub 2024 Aug 19.
本文引用的文献
1
Sublingual sufentanil (Zalviso) patient-controlled analgesia after total knee arthroplasty: a retrospective comparison with oxycodone with or without dexamethasone.
J Pain Res. 2018 Dec 14;11:3205-3210. doi: 10.2147/JPR.S185197. eCollection 2018.
2
Non-invasive patient-controlled analgesia in the management of acute postoperative pain in the hospital setting.
Curr Med Res Opin. 2018 Jul;34(7):1179-1186. doi: 10.1080/03007995.2018.1462785. Epub 2018 May 9.
3
Sufentanil sublingual tablet 30mcg for moderate-to-severe acute pain in the ED.
Am J Emerg Med. 2018 Jun;36(6):954-961. doi: 10.1016/j.ajem.2017.10.058. Epub 2017 Oct 31.
4
Sufentanil Sublingual Tablet 30 mcg for the Management of Pain Following Abdominal Surgery: A Randomized, Placebo-Controlled, Phase-3 Study.
Pain Pract. 2017 Sep;17(7):848-858. doi: 10.1111/papr.12531. Epub 2017 Feb 10.
5
Sublingual Sufentanil: A Review in Acute Postoperative Pain.
Drugs. 2016 Apr;76(6):719-29. doi: 10.1007/s40265-016-0571-6.
6
Sufentanil Sublingual Tablet System for the Management of Postoperative Pain after Knee or Hip Arthroplasty: A Randomized, Placebo-controlled Study.
Anesthesiology. 2015 Aug;123(2):434-43. doi: 10.1097/ALN.0000000000000746.
7
Pharmacokinetic properties of single- and repeated-dose sufentanil sublingual tablets in healthy volunteers.
Clin Ther. 2015 Jan 1;37(1):145-55. doi: 10.1016/j.clinthera.2014.11.001. Epub 2014 Dec 24.
8
Sufentanil sublingual tablet system for the management of postoperative pain following open abdominal surgery: a randomized, placebo-controlled study.
Reg Anesth Pain Med. 2015 Jan-Feb;40(1):22-30. doi: 10.1097/AAP.0000000000000152.
9
Sufentanil sublingual tablet system vs. intravenous patient-controlled analgesia with morphine for postoperative pain control: a randomized, active-comparator trial.
Pain Pract. 2014 Nov;14(8):679-88. doi: 10.1111/papr.12238. Epub 2014 Aug 25.
10
Pharmacokinetics of sublingual sufentanil tablets and efficacy and safety in the management of postoperative pain.
Reg Anesth Pain Med. 2013 Mar-Apr;38(2):131-9. doi: 10.1097/AAP.0b013e3182791157.
Zotero 插件